FdaApplication
ANDA 210831
Identifiers
- fda_app_no: ANDA210831
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2019-02-19 |
Products (12)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.025MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.2MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.088MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.05MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.175MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.112MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.137MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.15MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.3MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.125MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.075MG | TABLET;ORAL |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | 0.1MG | TABLET;ORAL |
12 products